Example: Heart Attack
Search clinical trials for: Dopamine Antagonists
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Aspergillus Fumigatus Infection
- Behavioral Resilience
- Class II Lesions
- Conjunctival Intraepithelial Neoplasia
- Fluorescence In Situ Hybridization
- Hemoglobin SS Disease With Crisis
- Narcolepsy and Hypersomnia
- Post Operative Local Anaesthesia
- Relapsed/Refractory High-Grade B-Cell Lymphoma
- Severe Behavior Disorder
- Shivering
- Stage IIB Gallbladder Cancer AJCC v8
- Transgender, HIV Continuum of Care
- View Full List
Sponsors and Collaborators
- Agricultural Research Development Agency (Public Organization)
- Canadian Radiostereometric Analysis Network
- Centro Cardiopatici Toscani
- Comunity pharmacy Lekarna Ormož
- Croma-Pharma GmbH
- Dong-A Pharmaceutical Co., Ltd.
- Laboratoire Chauvin
- Michel Giunta
- Rebecca Thornton
- Royal Devon and Exeter NHS Foundation Trust
- Sanofi
- Stony Brook Medicine
- VA Northern California Health Care System
- View Full List
Drug Interventions
- 6 mg GSK1278863 tablet
- AIN457A
- JNJ-38518168
- Non-steroidal anti-inflammatory drug (NSAID)
- Oral P2Y12 receptor blocker
- Placebo lozenge
- Recombinant Human Luteinizing Hormone
- Rivaroxaban (Xarelto,Bay 59-7939)
- Sinemet 25-100 Oral Tablet
- Sitagliptin 100 mg/simvastatin 40 mg FDC
- TQB2928 Injection
- novolog insulin
- placebo for BI 44847
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations